About CMTx Biotech

About company

CMTx Biotech is a clinical-stage biopharmaceutical company that focuses on repurposing a clinical-stage small molecule for the treatment of COVID-19 patients. It is currently preparing to advance into a Phase II clinical trial to demonstrate the safety and efficacy of its drug candidate in hospitalized COVID-19 patients. The company was founded in 2019 and is headquartered in Stony Brook, New York.